Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme

This phase II study aimed at determining the efficacy and safety of irinotecan combined with thalidomide in adults with recurrent glioblastoma multiforme (GBM) not taking enzyme-inducing anticonvulsants (EIACs). Adult patients (⩾18 years) with recurrent GBM with up to three relapses following surger...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Puduvalli, Vinay K., Giglio, Pierre, Groves, Morris D., Hess, Kenneth R., Gilbert, Mark R., Mahankali, Srikanth, Jackson, Edward F., Levin, Victor A., Conrad, Charles A., Hsu, Sigmund H., Colman, Howard, de Groot, John F., Ritterhouse, MeLesa G., Ictech, Sandra E., Alfred Yung, W. K.
Formato: Artigo
Idioma:Inglês
Publicado em: Duke University Press 2008
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2613824/
https://ncbi.nlm.nih.gov/pubmed/18314417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2007-060
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados